AbbVie, Novartis sue to block 340B drug discount law Tuesday, Aug 11, 2026 - Posted by Isabel Miller * The Chicago Tribune last week… Gov. […] But drug manufacturers argue that the savings are not being passed along to patients, and that hospitals and others are instead profiting from the program. And it is also beyond dispute that, without HB 2371, AbbVie would complete far fewer 340B priced sales. Novartis Pharmaceuticals made a nearly identical argument in its own complaint, asserting that HB 2371 cannot coexist with federal law. * Crain’s… AbbVie argues that the [340B] program is being abused with covered entities that now include commercial pharmacies like Walgreens and CVS, which “are not covered entities.”